• Reset
Results: 17725 found
LOCATIONS
Asia, Southern
LOCATIONS
Afghanistan
LOCATIONS
Europe
LOCATIONS
Africa, Northern
LOCATIONS
Oceania
LOCATIONS
Africa, Southern
LOCATIONS
Angola
LOCATIONS
America, Central
LOCATIONS
Antigua and Barbuda
LOCATIONS
America, Southern
LOCATIONS
Argentina
LOCATIONS
Australia
LOCATIONS
Austria
LOCATIONS
Bahamas
LOCATIONS
Asia, Western
LOCATIONS
Bangladesh
LOCATIONS
Barbados
LOCATIONS
Belarus
LOCATIONS
Belgium
LOCATIONS
Belize

Country Portfolio of Malaria Research & Investments

LOCATIONS
Africa, Western
LOCATIONS
Benin
LOCATIONS
America, Northern
LOCATIONS
Bermuda
LOCATIONS
Bhutan
LOCATIONS
Bolivia
LOCATIONS
Bosnia and Herzegovina
LOCATIONS
Botswana
LOCATIONS
Brazil
LOCATIONS
Asia, Southeastern
LOCATIONS
Burkina Faso
LOCATIONS
Africa, Eastern
LOCATIONS
Burundi
LOCATIONS
Cabo Verde

Country Portfolio of Malaria Research & Investments

LOCATIONS
Cambodia
LOCATIONS
Africa, Central
LOCATIONS
Cameroon
LOCATIONS
Canada
LOCATIONS
Central African Republic
LOCATIONS
Chad
LOCATIONS
Chile
LOCATIONS
Asia, Eastern
LOCATIONS
China

Country Portfolio of Malaria Research & Investments

LOCATIONS
Colombia
LOCATIONS
Comoros
LOCATIONS
Congo
LOCATIONS
Dem. Rep. of Congo
LOCATIONS
Costa Rica
LOCATIONS
Côte d'Ivoire
LOCATIONS
Croatia
LOCATIONS
Cuba
LOCATIONS
Czechia
LOCATIONS
Denmark
LOCATIONS
Djibouti
LOCATIONS
Dominica
LOCATIONS
Dominican Republic
LOCATIONS
Ecuador
LOCATIONS
Egypt
LOCATIONS
El Salvador

Country Portfolio of Malaria Research & Investments

LOCATIONS
Equatorial Guinea
LOCATIONS
Eritrea
LOCATIONS
Estonia
LOCATIONS
Ethiopia
LOCATIONS
Finland
LOCATIONS
France
LOCATIONS
French Guiana
LOCATIONS
Gabon
LOCATIONS
The Gambia
LOCATIONS
Germany
LOCATIONS
Ghana

Country Portfolio of Malaria Research & Investments

LOCATIONS
Greece

Country Portfolio of Malaria Research & Investments

LOCATIONS
Grenada
LOCATIONS
Guam
LOCATIONS
Guatemala
LOCATIONS
Guinea
LOCATIONS
Guinea-Bissau
LOCATIONS
Guyana
LOCATIONS
Haiti
LOCATIONS
Honduras
LOCATIONS
Hong Kong
LOCATIONS
Hungary
LOCATIONS
India
LOCATIONS
Indonesia
LOCATIONS
Iran
LOCATIONS
Ireland
LOCATIONS
Israel
LOCATIONS
Italy
LOCATIONS
Jamaica
LOCATIONS
Japan
LOCATIONS
Jordan
LOCATIONS
Asia, Central
LOCATIONS
Kazakhstan
LOCATIONS
Kenya

Country Portfolio of Malaria Research & Investments

LOCATIONS
North Korea
LOCATIONS
South Korea
LOCATIONS
Lao PDR
LOCATIONS
Latvia
LOCATIONS
Lebanon
LOCATIONS
Lesotho
LOCATIONS
Liberia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Liechtenstein
LOCATIONS
Lithuania
LOCATIONS
Luxembourg
LOCATIONS
Madagascar
LOCATIONS
Malawi

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malaysia
LOCATIONS
Mali

Country Portfolio of Malaria Research & Investments

LOCATIONS
Malta
LOCATIONS
Mauritania
LOCATIONS
Mauritius

Country Portfolio of Malaria Research & Investments

LOCATIONS
Mexico
LOCATIONS
Morocco
LOCATIONS
Mozambique

Country Portfolio of Malaria Research & Investments

LOCATIONS
Myanmar
LOCATIONS
Namibia
LOCATIONS
Nepal
LOCATIONS
The Netherlands
LOCATIONS
New Zealand
LOCATIONS
Nicaragua
LOCATIONS
Niger
LOCATIONS
Nigeria

Country Portfolio of Malaria Research & Investments

LOCATIONS
Norway
LOCATIONS
Pakistan
LOCATIONS
Panama
LOCATIONS
Papua New Guinea
LOCATIONS
Paraguay

Country Portfolio of Malaria Research & Investments

LOCATIONS
Peru

Country Portfolio of Malaria Research & Investments

LOCATIONS
Philippines
LOCATIONS
Poland
LOCATIONS
Portugal
LOCATIONS
Qatar
LOCATIONS
Réunion

Country Portfolio of Malaria Research & Investments

LOCATIONS
Romania
LOCATIONS
Russian Federation
LOCATIONS
Rwanda

Country Portfolio of Malaria Research & Investments

LOCATIONS
Saint Kitts and Nevis
LOCATIONS
Saint Lucia
LOCATIONS
Saint Vincent and the Grenadines
LOCATIONS
Sao Tome and Principe
LOCATIONS
Saudi Arabia
LOCATIONS
Senegal

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sierra Leone
LOCATIONS
Singapore
LOCATIONS
Slovakia
LOCATIONS
Solomon Islands
LOCATIONS
Somalia
LOCATIONS
South Africa

Country Portfolio of Malaria Research & Investments

LOCATIONS
South Sudan
LOCATIONS
Spain
LOCATIONS
Sri Lanka

Country Portfolio of Malaria Research & Investments

LOCATIONS
Sudan
LOCATIONS
Suriname
LOCATIONS
Eswatini
LOCATIONS
Sweden
LOCATIONS
Switzerland
LOCATIONS
Syria
LOCATIONS
Tajikistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Tanzania

Country Portfolio of Malaria Research & Investments

LOCATIONS
Thailand
LOCATIONS
Togo
LOCATIONS
Trinidad and Tobago
LOCATIONS
Tunisia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Türkiye
Country Portfolio of Malaria Research & Investments
LOCATIONS
Turkmenistan

Country Portfolio of Malaria Research & Investments

LOCATIONS
Uganda
LOCATIONS
United Arab Emirates
LOCATIONS
United Kingdom
LOCATIONS
United States
LOCATIONS
Uruguay
LOCATIONS
Vanuatu
LOCATIONS
Venezuela
LOCATIONS
Vietnam
LOCATIONS
Yemen
LOCATIONS
Zambia

Country Portfolio of Malaria Research & Investments

LOCATIONS
Zimbabwe
Projects: 6768 Updates: 1851 Resources: 1288 Institutions: 2619 Principal Investigators: 5071 Deep Dives: 24
Jan 2014 —
Sep 2015
Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day
Myanmar Oxford Clinical Research Unit (MOCRU)
Drug-based Strategies
Jun 2014 —
Feb 2015
Assessment of Artesunate/Mefloquine in the Peruvian Amazon
U.S. Naval Medical Research Unit 6 (NAMRU-6) Peru
Drug-based Strategies
Sep 2013 —
Jul 2015
Low Dose Primaquine for Clearance of Gametocytes
National Center for Research and Training for Malaria (CNRFP) Burkina Faso
Drug-based Strategies | Enabling Technologies & Assays
Mar 2015 —
May 2016
Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria
Eijkman Institute for Molecular Biology (EIMB) | Menzies School of Health Research
Drug-based Strategies
Principal Investigators
Jonathan L. Vennerstrom
Principal Investigators
Dominic Kwiatkowski †
Apr 2005 —
Mar 2024

$7.82M

Immunological characterization of the P. vivax DBP
University of South Florida
Basic Science | Immunology | P. vivax | Vaccines
Aug 2014 —
Jul 2016

$411,125

Defining epitopes of Plasmodium vivax RBP that are potential vaccine targets
Enabling Technologies & Assays | P. vivax | Vaccines
Jul 2014 —
Jun 2015

$844,000

Optimization of chimeric multi-stage immunogens for malaria vaccine development
Emory University
P. vivax | Product Development | Vaccines
Mar 2015 —
Feb 2020

$2.73M

Multivalent chimeric subunit malaria vaccines
Drexel University (DU)
Immunology | Vaccines
Jul 2014 —
Jun 2016

$454,070

Midgut Transcriptome and Proteome Analyses: Non-model Anopheline Malaria Vectors
Johns Hopkins Bloomberg School of Public Health (JHBSPH)
Enabling Technologies & Assays | Measurement of Transmission
Jul 2014 —
Mar 2019
Strain-specific Immunity to Plasmodium vivax malaria
Louis Stokes Cleveland VA Medical Center
Enabling Technologies & Assays | Immunology | P. vivax | Product Development | Vaccines
Mar 2014 —
Mar 2017

$499,104

Modelling the contribution of relapse infections to the epidemiology and control of Plasmodium vivax malaria
Imperial College London
Combination of Interventions | Measurement of Transmission | Modeling | P. vivax
Feb 2014 —
Jan 2017

$442,000

Dissecting Chloroquine Resistance in Plasmodium vivax
University of North Carolina System
Drug-based Strategies | Genetics and Genomics | P. vivax
Sep 2013 —
Aug 2018

$3.56M

Madagascar P. vivax Invasion of Duffy-negative Red Cells
Case Western Reserve University
Genetics and Genomics | P. vivax
Feb 2014 —
Jan 2019

$869,147

Genetic determinants of Plasmodium vivax relapse
University of North Carolina System
Genetics and Genomics | P. vivax
Aug 2013 —
Jul 2016

$509,000

Molecular Epidemiology of Vivax Malaria in Ethiopia
University of California Irvine (UCI)
Asymptomatic Reservoir | Genetics and Genomics | P. vivax
Jul 2013 —
Jun 2018

$872,305

Human T Cell Immunology of Plasmodium Vivax Malaria
University of Florida
Asymptomatic Reservoir | P. vivax
May 2013 —
Apr 2019

$672,200

Discovery & validation of novel P. vivax antigens for identification and monitoring
Mahidol University
Enabling Technologies & Assays | Measurement of Transmission | P. vivax | Residual Transmission
May 2013 —
Apr 2019

$1.77M

Genomic Analyses of Plasmodium vivax Responses to Antimalarial Drugs in Cambodia
Cleveland Clinic Lerner College of Medicine | University of Maryland, Baltimore (UMB)
Drug Resistance | Genetics and Genomics | P. vivax
« First
Last »